These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 7140965)
1. Metabolism of metergoline in the rat. Vicario GP; Battaglia R; Bernardi L; Arcamone F Farmaco Sci; 1982 Oct; 37(10):651-62. PubMed ID: 7140965 [TBL] [Abstract][Full Text] [Related]
2. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioavailability of metergoline in healthy volunteers after single i.v. and oral administration. Martini A; Moro E; Marrari P; Pacciarini MA; Sega R; Dell'Osso L; Bertelli A; Tamassia V Int J Clin Pharmacol Res; 1983; 3(1):27-34. PubMed ID: 6679505 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats. Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879 [TBL] [Abstract][Full Text] [Related]
5. Metabolism and excretion of atorvastatin in rats and dogs. Black AE; Hayes RN; Roth BD; Woo P; Woolf TF Drug Metab Dispos; 1999 Aug; 27(8):916-23. PubMed ID: 10421619 [TBL] [Abstract][Full Text] [Related]
6. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone. Prakash C; Kamel A; Anderson W; Howard H Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052 [TBL] [Abstract][Full Text] [Related]
7. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845 [TBL] [Abstract][Full Text] [Related]
8. Tissue distribution and biotransformation of zopolrestat, an aldose reductase inhibitor, in rats. Schneider RP; Fouda HG; Inskeep PB Drug Metab Dispos; 1998 Nov; 26(11):1149-59. PubMed ID: 9806959 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C; Soliman V Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats. Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629 [TBL] [Abstract][Full Text] [Related]
11. Disposition of the opioid antagonist, LY255582, in rats and dogs. Swanson SP; Catlow J; Pohland RC; Chay SH; Johnson T Drug Metab Dispos; 1995 Sep; 23(9):916-21. PubMed ID: 8565781 [TBL] [Abstract][Full Text] [Related]
12. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of vincamine in the rat in vivo and in vitro. Vereczkey L; Tamás J; Czira G; Szporny L Arzneimittelforschung; 1980; 30(11):1860-5. PubMed ID: 7192994 [TBL] [Abstract][Full Text] [Related]
14. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats. Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648 [TBL] [Abstract][Full Text] [Related]
15. Biotransformation of epomediol. I--Isolation and identification of main metabolites in the rat. Ventura P; Selva A Biomed Mass Spectrom; 1982 Jan; 9(1):18-21. PubMed ID: 7059659 [TBL] [Abstract][Full Text] [Related]
16. Metabolism and disposition of moxonidine in Fischer 344 rats. He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314 [TBL] [Abstract][Full Text] [Related]
17. The orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans. Denissen JF; Grabowski BA; Johnson MK; Boyd SA; Uchic JT; Stein H; Cepa S; Hill P Drug Metab Dispos; 1994; 22(6):880-8. PubMed ID: 7895605 [TBL] [Abstract][Full Text] [Related]
18. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees. Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025 [TBL] [Abstract][Full Text] [Related]
19. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs. Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948 [TBL] [Abstract][Full Text] [Related]
20. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C; Cui D Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]